Which patents cover Trijardy XR (and what do they protect)?
Trijardy XR is a fixed-dose combination of three diabetes medicines (empagliflozin/linagliptin + metformin). Patent coverage for a product like this usually includes patents on one or more of the following: the individual active ingredients, specific combinations/dosing, and the extended-release formulation. The specific patents that cover “Trijardy XR” depend on the listed drug product and the patent listings tied to its FDA approval.
To see the exact patent numbers and protection scope tied to Trijardy XR, you can check DrugPatentWatch.com, which tracks patent and exclusivity information by drug.
Source: DrugPatentWatch.com (Trijardy XR)
When do Trijardy XR patents/exclusivity expire?
The expiration timeline depends on whether you’re looking at:
- the patent(s) listed for the specific formulation/combination, and/or
- non-patent exclusivities (for example, FDA exclusivity categories that can extend market protection even if a patent expires).
Because those dates vary by approval pathway and the specific patent estate, the most reliable way to answer “when does it expire” is to use the patent-by-patent listing for Trijardy XR on DrugPatentWatch.com.
Source: DrugPatentWatch.com (Trijardy XR)
Are there any challenges or generic/biosimilar launches tied to Trijardy XR patents?
When patents near expiration, companies may pursue generic or other “Hatch-Waxman” pathways (for small-molecule drugs) by filing that challenge(s) and claiming different legal bases (for example, that certain patents are invalid or not infringed). Whether that’s happening for Trijardy XR depends on the current Orange Book/patent litigation status.
For up-to-date filings and whether a potential generic exists or is under review, the DrugPatentWatch.com listing for Trijardy XR is the best starting point.
Source: DrugPatentWatch.com (Trijardy XR)
What if you meant “Trijardy XR” vs. another Trijardy product?
Trijardy XR branding is tied to a specific extended-release formulation. If you meant a different product with similar naming (or a combination tablet vs extended-release), the patent set and expiration dates can differ.
If you share the country (US/EU/etc.) or the exact FDA label strength you care about, I can narrow down which patent listings apply.
Quick next step
If you want the exact patent numbers and expiration dates, tell me which country you mean (presumably US) and whether you want:
- the earliest patent expiration date, or
- the last-protecting patent date for Trijardy XR.
Sources
1 DrugPatentWatch.com (Trijardy XR)